{"id":"NCT00662675","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","briefTitle":"A Study of the Efficacy and Tolerability of Pancrelipase Microtablet (MT) Capsules for the Treatment of Cystic Fibrosis-dependent Exocrine Pancreatic Insufficiency","officialTitle":"A Randomized Double-blind (Withdrawal) Phase 3 Study to Evaluate the Efficacy and Tolerability of Pancrelipase MT Capsules Compared With Placebo in the Treatment of Subjects With Cystic Fibrosis-dependent Exocrine Pancreatic Insufficiency","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-08","primaryCompletion":"2009-02","completion":"2009-02","firstPosted":"2008-04-21","resultsPosted":"2010-03-17","lastUpdate":"2014-05-09"},"enrollment":40,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Exocrine Pancreatic Insufficiency","Steatorrhea","Malabsorption Syndromes","Cystic Fibrosis"],"interventions":[{"type":"DRUG","name":"Pancrease MT 10.5, or MT 21","otherNames":[]},{"type":"DRUG","name":"Placebo for Pancrease MT 10.5 or MT 21","otherNames":[]}],"arms":[{"label":"001","type":"EXPERIMENTAL"},{"label":"002","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to assess the effectiveness and safety of oral pancrelipase MT in the treatment of adult and pediatric/adolescent cystic fibrosis (CF) patients with clinical symptoms of exocrine pancreatic insufficiency (EPI).","primaryOutcome":{"measure":"Change in the Coefficient of Fat Absorption (COA-fat Percent)","timeFrame":"72-hours stool collection in the open-label phase to the end of 72-hours stool collection in the double-blind withdrawal phase.","effectByArm":[{"arm":"Placebo","deltaMin":-34.1,"sd":23.03},{"arm":"PANCREASE MT","deltaMin":-1.5,"sd":5.88}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"7 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":6},"locations":{"siteCount":11,"countries":["United States","Canada"]},"refs":{"pmids":[],"seeAlso":["http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_JNJ_6051&studyid=77&filename=CR014719_CSR.pdf"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":20},"commonTop":["Abdominal pain","Abdominal pain upper","Diarrhoea","Flatulence","Abnormal faeces"]}}